Mydecine Innovations Group Inc (MYCOF)
0.0112
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Mydecine Innovations Group Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | 20.61 |
| September 30, 2021 | |
| June 30, 2021 | 0.0303 |
| March 31, 2021 | 0.0239 |
| December 31, 2020 | 0.8312 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.4112 |
| December 31, 2018 | 24.84 |
| September 30, 2018 | 0.4999 |
| June 30, 2018 | -1.983 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.0293 |
| December 31, 2017 | 0.063 |
| September 30, 2017 | 0.074 |
| June 30, 2017 | 0.0764 |
| March 31, 2017 | 0.0627 |
| December 31, 2016 | 0.1064 |
| September 30, 2016 | -4.490 |
| June 30, 2016 | -6.418 |
| March 31, 2016 | -8.086 |
| December 31, 2015 | -15.98 |
| September 30, 2015 | 2.303 |
| June 30, 2015 | 2.101 |
| March 31, 2015 | 61.96 |
| December 31, 2014 | 16.72 |
| September 30, 2014 | 8.601 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
20.61
Maximum
Dec 2021
2.149
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | 0.00 |
| Venus Concept Inc | -5.346 |
| Juva Life Inc | 0.9671 |
| Lucy Scientific Discovery Inc | 14.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.277M |
| Total Liabilities (Quarterly) | 8.072M |
| Shareholders Equity (Quarterly) | -4.795M |